Bank of New York Mellon’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.36M | Buy |
34,263
+2,181
| +7% | +$145K | ﹤0.01% | 2851 |
|
|
2026
Q1 | $1.99M | Sell |
32,082
-3,457
| -10% | -$218K | ﹤0.01% | 2817 |
|
|
2025
Q4 | $1.99M | Sell |
35,539
-9,989
| -22% | -$579K | ﹤0.01% | 2836 |
|
|
2025
Q3 | $2.87M | Sell |
45,528
-3,608
| -7% | -$213K | ﹤0.01% | 2624 |
|
|
2025
Q2 | $2.8M | Buy |
49,136
+524
| +1% | +$28.5K | ﹤0.01% | 2583 |
|
|
2025
Q1 | $2.72M | Buy |
48,612
+1,277
| +3% | +$76.5K | ﹤0.01% | 2535 |
|
|
2024
Q4 | $2.91M | Sell |
47,335
-105
| -0.2% | -$6.79K | ﹤0.01% | 2582 |
|
|
2024
Q3 | $3.17M | Sell |
47,440
-2,164
| -4% | -$147K | ﹤0.01% | 2539 |
|
|
2024
Q2 | $3.31M | Buy |
49,604
+1,391
| +3% | +$94.7K | ﹤0.01% | 2536 |
|
|
2024
Q1 | $3.43M | Buy |
48,213
+11,710
| +32% | +$878K | ﹤0.01% | 2499 |
|
|
2023
Q4 | $3.07M | Buy |
36,503
+5,104
| +16% | +$423K | ﹤0.01% | 2608 |
|
|
2023
Q3 | $2.7M | Buy |
31,399
+208
| +0.7% | +$19.2K | ﹤0.01% | 2642 |
|
|
2023
Q2 | $2.91M | Buy |
31,191
+31
| +0.1% | +$2.92K | ﹤0.01% | 2627 |
|
|
2023
Q1 | $2.95M | Sell |
31,160
-1,108
| -3% | -$102K | ﹤0.01% | 2582 |
|
|
2022
Q4 | $3.24M | Buy |
32,268
+12,944
| +67% | +$1.18M | ﹤0.01% | 2583 |
|
|
2022
Q3 | $1.65M | Buy |
19,324
+1,250
| +7% | +$110K | ﹤0.01% | 2952 |
|
|
2022
Q2 | $1.55M | Sell |
18,074
-1,874
| -9% | -$160K | ﹤0.01% | 2976 |
|
|
2022
Q1 | $1.79M | Buy |
19,948
+389
| +2% | +$35.8K | ﹤0.01% | 2996 |
|
|
2021
Q4 | $1.96M | Sell |
19,559
-7,840
| -29% | -$800K | ﹤0.01% | 3010 |
|
|
2021
Q3 | $2.54M | Buy |
27,399
+666
| +2% | +$58.8K | ﹤0.01% | 2850 |
|
|
2021
Q2 | $2.27M | Buy |
26,733
+1,168
| +5% | +$101K | ﹤0.01% | 2904 |
|
|
2021
Q1 | $2.21M | Buy |
25,565
+227
| +0.9% | +$20K | ﹤0.01% | 2873 |
|
|
2020
Q4 | $2.13M | Buy |
25,338
+3,431
| +16% | +$292K | ﹤0.01% | 2811 |
|
|
2020
Q3 | $1.75M | Sell |
21,907
-1,050
| -5% | -$87.1K | ﹤0.01% | 2750 |
|
|
2020
Q2 | $2.03M | Buy |
22,957
+763
| +3% | +$68.5K | ﹤0.01% | 2662 |
|
|
2020
Q1 | $2.09M | Sell |
22,194
-42
| -0.2% | -$3.9K | ﹤0.01% | 2521 |
|
|
2019
Q4 | $2.4M | Sell |
22,236
-1,174
| -5% | -$119K | ﹤0.01% | 2706 |
|
|
2019
Q3 | $2.24M | Buy |
23,410
+235
| +1% | +$21.8K | ﹤0.01% | 2687 |
|
|
2019
Q2 | $2.22M | Sell |
23,175
-131
| -0.6% | -$11K | ﹤0.01% | 2743 |
|
|
2019
Q1 | $2.06M | Buy |
23,306
+855
| +4% | +$75.2K | ﹤0.01% | 2761 |
|
|
2018
Q4 | $1.87M | Sell |
22,451
-3,224
| -13% | -$284K | ﹤0.01% | 2757 |
|
|
2018
Q3 | $2.42M | Buy |
25,675
+605
| +2% | +$57.8K | ﹤0.01% | 2742 |
|
|
2018
Q2 | $2.76M | Buy |
25,070
+660
| +3% | +$68.9K | ﹤0.01% | 2675 |
|
|
2018
Q1 | $2.41M | Buy |
24,410
+623
| +3% | +$55.6K | ﹤0.01% | 2709 |
|
|
2017
Q4 | $1.94M | Sell |
23,787
-4,521
| -16% | -$353K | ﹤0.01% | 2859 |
|
|
2017
Q3 | $2.08M | Buy |
28,308
+1,236
| +5% | +$88.9K | ﹤0.01% | 2814 |
|
|
2017
Q2 | $1.96M | Sell |
27,072
-2,420
| -8% | -$159K | ﹤0.01% | 2864 |
|
|
2017
Q1 | $1.84M | Buy |
29,492
+815
| +3% | +$51.3K | ﹤0.01% | 2902 |
|
|
2016
Q4 | $2.09M | Buy |
28,677
+6,717
| +31% | +$437K | ﹤0.01% | 2827 |
|
|
2016
Q3 | $1.31M | Buy |
21,960
+411
| +2% | +$26.1K | ﹤0.01% | 3027 |
|
|
2016
Q2 | $1.36M | Buy |
21,549
+523
| +2% | +$33.7K | ﹤0.01% | 2946 |
|
|
2016
Q1 | $1.31M | Buy |
21,026
+513
| +3% | +$30.3K | ﹤0.01% | 2899 |
|
|
2015
Q4 | $1.2M | Sell |
20,513
-3,569
| -15% | -$202K | ﹤0.01% | 3043 |
|
|
2015
Q3 | $1.3M | Sell |
24,082
-1,639
| -6% | -$89.4K | ﹤0.01% | 3019 |
|
|
2015
Q2 | $1.53M | Buy |
25,721
+1,243
| +5% | +$70K | ﹤0.01% | 3083 |
|
|
2015
Q1 | $1.47M | Buy |
24,478
+413
| +2% | +$24.3K | ﹤0.01% | 3073 |
|
|
2014
Q4 | $1.45M | Sell |
24,065
-1,509
| -6% | -$83.6K | ﹤0.01% | 3068 |
|
|
2014
Q3 | $1.25M | Sell |
25,574
-438
| -2% | -$22.2K | ﹤0.01% | 3167 |
|
|
2014
Q2 | $1.34M | Buy |
26,012
+504
| +2% | +$25.9K | ﹤0.01% | 3146 |
|
|
2014
Q1 | $1.48M | Buy |
25,508
+506
| +2% | +$27.6K | ﹤0.01% | 3079 |
|
|
2013
Q4 | $1.43M | Buy |
25,002
+1,256
| +5% | +$68.9K | ﹤0.01% | 3090 |
|
|
2013
Q3 | $1.41M | Buy |
23,746
+2,611
| +12% | +$143K | ﹤0.01% | 3056 |
|
|
2013
Q2 | $1.15M | Buy |
+21,135
| New | +$995K | ﹤0.01% | 3117 |
|
Other funds holding UTMD
RHJA
CCMINC
EHC
RWM
Bank of New York Mellon's UTMD Position: Q2 2026 in Review
Bank of New York Mellon increased its Utah Medical Products (UTMD) stake by 6.8% in Q2 2026, buying an estimated $145K and bringing the position to 34,263 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2851.
Bank of New York Mellon first reported a position in UTMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.43M in Q1 2024. 56 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.
- Bank of New York Mellon held 34,263 shares of Utah Medical Products worth $2.36M as of Q2 2026.
- Bank of New York Mellon bought 2,181 Utah Medical Products shares in Q2 2026, an estimated $145K.
- Utah Medical Products made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2851 holding.
- Bank of New York Mellon first reported a position in Utah Medical Products in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Utah Medical Products position peaked at $3.43M in Q1 2024.
- 56 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.